What's in Nguyen, Davis B., M.D.'s pipeline?

Nguyen, Davis B., M.D. has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Nguyen, Davis B., M.D.'s portfolio?

Top competitors by shared drug class: Baxter Healthcare Corporation, Massachusetts General Hospital, Nycomed.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/nguyen-davis-b-m-d.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Nguyen, Davis B., M.D. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nguyen, Davis B., M.D. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Fibrin Sealant (Artiss)	Fibrin Sealant (Artiss)	marketed	Fibrin sealant	Fibrinogen; thrombin substrate	Surgery/Hemostasis

Therapeutic area mix

Surgery/Hemostasis · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Baxter Healthcare Corporation · 1 shared drug class
Massachusetts General Hospital · 1 shared drug class
Nycomed · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Nguyen, Davis B., M.D.:

Cite this brief

Drug Landscape (2026). Nguyen, Davis B., M.D. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nguyen-davis-b-m-d. Accessed 2026-05-17.